Physician profile
Sandra Dee
NPI 1962474254
$1,079.05
in general payments reported to CMS, 2019-2025
20 companies · $156 in 2025
The $156 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2020: $89.15 · 2021: $49.36 · 2022: $136 · 2023: $204 · 2024: $198 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $558.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $139.03 | 2019-2025 | Doc Band |
| Angiodynamics, INC. | $123.29 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $112.01 | 2021-2023 | Cuvitru |
| Sanofi Pasteur INC. | $87.00 | 2020-2023 | |
| Supernus Pharmaceuticals, INC. | $76.26 | 2022-2024 | Qelbree |
| Pfizer INC. | $62.69 | 2019-2025 | |
| Glaxosmithkline, LLC. | $62.38 | 2019-2023 | Bexsero |
| Ars Pharmaceuticals Operations, INC. | $52.69 | 2025 | Neffy |
| Sanofi-Aventis U.S. LLC | $52.43 | 2024 | |
| Incyte Corporation | $43.30 | 2022-2024 | Opzelura |
| Ironshore Pharmaceuticals INC. | $40.06 | 2020-2022 | |
| Collegium Pharmaceutical, INC. | $39.68 | 2025 | Jornay Pm |
| Pharming Healthcare, INC. | $32.67 | 2023 | Ruconest |
| Merck Sharp & Dohme LLC | $31.64 | 2022-2023 | Vaxneuvance |
| Tris Pharma INC | $29.48 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $28.46 | 2024-2025 | Zoryve |
| Genentech USA, INC. | $23.37 | 2019 | |
| Alk-Abello, INC | $17.75 | 2025 | Neffy, Ragwitek, Odactra |
| Corium, LLC | $13.14 | 2023 | Azstarys |
| Amneal Pharmaceuticals LLC | $11.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Dee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.